This week, the first clinical trial of gene therapy for Parkinson's disease began. We'll talk about this experimental treatment.
Michael Kaplitt, M.D., Ph.D.
* Assistant Professor, Neurological Surgery Weill Cornell Medical College
* Director, Center for Stereotactic and Functional Neurosurgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York
Theodore Friedmann, M.D.
*Chair, Recombinant DNA Advisory Committee (RAC), National Institutes of Health Professor, Pediatrics
* Muriel Jeannette Whitehill Chair in Biomedical Ethics
* Director, Program in Human Gene Therapy University of California San Diego, San Diego, California